Administration of Maresin-1 ameliorates the physiopathology of experimental autoimmune encephalomyelitis

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1742-2094
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Administration of Maresin-1 ameliorates the physiopathology of experimental autoimmune encephalomyelitis ; volume:19 ; number:1 ; day:2 ; month:2 ; year:2022 ; pages:1-18 ; date:12.2022
Journal of neuroinflammation ; 19, Heft 1 (2.2.2022), 1-18, 12.2022

Creator
Sánchez-Fernández, Alba
Zandee, Stephanie
Mastrogiovanni, Mauricio
Charabati, Marc
Rubbo, Homero
Prat, Alexandre
López-Vales, Rubèn
Contributor
SpringerLink (Online service)

DOI
10.1186/s12974-022-02386-1
URN
urn:nbn:de:101:1-2022051119280607599201
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:28 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Sánchez-Fernández, Alba
  • Zandee, Stephanie
  • Mastrogiovanni, Mauricio
  • Charabati, Marc
  • Rubbo, Homero
  • Prat, Alexandre
  • López-Vales, Rubèn
  • SpringerLink (Online service)

Other Objects (12)

Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis

Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis

Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis

Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis

ADAMTS13 ameliorates inflammatory responses in experimental autoimmune encephalomyelitis

ADAMTS13 ameliorates inflammatory responses in experimental autoimmune encephalomyelitis

Inhibition of SLPI ameliorates disease activity in experimental autoimmune encephalomyelitis

Inhibition of SLPI ameliorates disease activity in experimental autoimmune encephalomyelitis

Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis

Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis

Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis

Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis

Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation

Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation

Role of eosinophils in experimental autoimmune encephalomyelitis

Role of eosinophils in experimental autoimmune encephalomyelitis

Claudin-1 induced sealing of blood–brain barrier tight junctions ameliorates chronic experimental autoimmune encephalomyelitis

Claudin-1 induced sealing of blood–brain barrier tight junctions ameliorates chronic experimental autoimmune encephalomyelitis

P2x7 deficiency suppresses development of experimental autoimmune encephalomyelitis

P2x7 deficiency suppresses development of experimental autoimmune encephalomyelitis

Neonatal tolerance and experimental autoimmune encephalomyelitis

Hochschulschrift

Neonatal tolerance and experimental autoimmune encephalomyelitis

Neuronal Response to Experimental Autoimmune Encephalomyelitis

Neuronal Response to Experimental Autoimmune Encephalomyelitis

Related objects